Johnson Financial Group Inc (Wisconsin)’s Revolution Medicines RVMD Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.5K	Buy	+200	New	+$29.2K	﹤0.01%	507

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s RVMD Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) opened a new position in Revolution Medicines (RVMD) in Q2 2026: 200 shares worth $37.5K. The stake represents ﹤0.01% of the portfolio and ranks #507 among its holdings.

688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Johnson Financial Group Inc (Wisconsin) held 200 shares of Revolution Medicines worth $37.5K as of Q2 2026.
Revolution Medicines was a new Johnson Financial Group Inc (Wisconsin) position in Q2 2026.
Revolution Medicines made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #507 holding.
688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.